Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie
NCT01479127: Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

Checkmark P2 data: Advanced Parkinson's Disease
Dec 2012 - Dec 2012: P2 data: Advanced Parkinson's Disease
Completed
2
8
Japan
ABT-SLV187, DUOPA™ (carbidopa and levodopa Enteral Suspension), DUODOPA®, Levodopa-carbidopa intestinal gel (LCIG), Oral Levodopa/Carbidopa, Infusion Pump: CADD-Legacy® 1400 Pump, NJ-Tube: Silicon ED Tube, Adaptor: Hakko Adaptor
AbbVie (prior sponsor, Abbott), Abbott Japan Co.,Ltd
Advanced Parkinson's Disease
07/12
07/12
NCT01291537 / 2010-020769-25: Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients

Completed
2
56
Europe
Duodopa, best médical treatment
Poitiers University Hospital
Parkinson's Disease
03/16
 

Download Options